Monday, October 04, 2021 11:10:51 AM
COVID-19 Drug/Capsules/Pills Plus Cancer Drugs incoming!! FDA Approval Submission and then a Partnership or Buy-Out offer from a Pharma giant like, Pfizer Inc. or Johnson and Johnson Inc. will send the PPS to Dollars!!
Folks, Biotech stock GLSI ran from $3 through $158 in a single day couple of months ago! I think SBFM is NEXT!!
Know What You Own:
Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern, 2021-08-12 !! Just amazing !!
https://ca.finance.yahoo.com/news/sunshine-biopharma-coronavirus-treatment-anticipated-130000512.html
Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer, 2021-07-08!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-employs-mrna-vaccine-130000648.html
Sunshine Biopharma’s Adva-27a Destroys Cancer Cells Expressing P-glycoprotein, a Marker Present in Over 50% of All Cancer Types, 2021-05-25 - This is gonna be HUGE beyond imagination!
https://ca.finance.yahoo.com/news/sunshine-biopharma-adva-27a-destroys-120000080.html
Sunshine Biopharma Upgrades COVID-19 Provisional Patent Application to Full PCT Application, 2021-05-04.
https://ca.finance.yahoo.com/news/sunshine-biopharma-upgrades-covid-19-120000354.html
Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment, 2021-04-19..Just amazing!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-reports-favorable-mtd-120000152.html
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a, the Company's Flagship Anticancer Compound Until 2033-Just Beautiful!
https://finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-130000340.html
SBFM has a number of shares outstanding only 510.09 million including restricted shares of 60.01 Million. Biotech stock with huge potential and such a low OS in OTC, PPS @ $2..$5..$7..$10..$20..$25++??, anything is possible.
https://www.otcmarkets.com/stock/SBFM/security
Shorts are Screwed up here. Total Naked Shorted Position is 13.35 Million. Huge Short Squeeze is imminent. Shorts are gonna be scrambling, weeping and biting their nails.
https://marketwirenews.com/stock/sbfm/short/
Let's go SBFM to $5++ and NASDAQ !!
SHARE VALUATION:
As per MNP (one of the largest public accountancy firms in Canada), an estimated Fair Market Value of issued and outstanding shares of SBFM as at March 31, 2017 was in the range of $977.0 million to $1,133.0 million.
https://finance.yahoo.com/news/sunshine-biopharma-releases-results-independent-130000009.html
So, Estimated PPS of SBFM (in 2017) = $1,100 million/510.09 million = $2.16 (without recent developments)
Folks! act prudently and be financially solvent at this very very difficult time.
RECENT DEVELOPMENTS:
Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-0-9-130000806.html
Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned, 2021-06-09
https://ca.finance.yahoo.com/news/sunshine-biopharma-mice-study-covid-130000849.html
Sunshine Biopharma Eliminates $250,000 in Variable Rate Convertible Debt and Provides an Update on Status of OTCQB Uplisting
https://ca.finance.yahoo.com/news/sunshine-biopharma-eliminates-250-000-120000108.html
Sunshine Biopharma Reports $1.797 Million Cash in 2021 Q1 Filing
https://ca.finance.yahoo.com/news/sunshine-biopharma-reports-improved-cash-120000104.html
RB Capital Increases Investment in Sunshine Biopharma
https://ca.finance.yahoo.com/news/rb-capital-increases-investment-sunshine-120000335.html
Sunshine Biopharma Reaches $2,000,000+ Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-reaches-2-000-130000199.html
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033, 2021-03-11
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-140000158.html
Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-recently-ordered-140000929.html
Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements
https://ca.finance.yahoo.com/news/sunshine-biopharma-launches-ecommerce-store-141400955.html
Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds, Feb. 4, 2021
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-exclusive-license-130000848.html
Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-fourth-tranche-133000911.html
Sunshine Biopharma’s Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK, Dec. 22, 2020
https://ca.finance.yahoo.com/news/sunshine-biopharma-coronavirus-treatment-anticipated-130000305.html
Sunshine Biopharma Orders a New Batch of Adva-27a for Testing on TOPII Amplified Cancers, Dec. 8, 2020
https://ca.finance.yahoo.com/news/sunshine-biopharma-orders-batch-adva-130000761.html
Sunshine Biopharma Paid Off Convertible Notes in Cash Preventing New Shares From Hitting the Market, December 3, 2020..Just Beautiful!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-pays-off-convertible-130000473.html
Sunshine Biopharma Signed an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound....This is a HUGE NEWS!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-agreement-montreal-130000919.html
https://wallstreetwindow.com/2020/10/shares-of-sunshine-biopharma-inc-otcmkts-sbfm-rise-today-on-covid-drug-news-tim-bellamy-10-19-2020/
Recent SBFM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
- Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM